Abstract
Several new antibiotic agents for urinary tract infections include β-lactam/β-lactamase inhibitor combinations with cephalosporins and carbapenems. Siderophore cephalosporins, novel aminoglycosides, fluoroquinolones, and tetracyclines are also in clinical development. Nevertheless, antimicrobial stewardship remains important in preserving the utility of the antibiotic agents currently available.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
